Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Xi-shan Hao"'
Autor:
Francesco Bertoni, Sergio B. Cogliatti, Daniela Capello, Xi-shan Hao, Hua-qing Wang, Hui-lai Zhang, Franco Cavalli
Publikováno v:
Cancer Biology & Medicine, Vol 8, Iss 2, Pp 65-70 (2011)
Mantle cell lymphoma (MCL) is an aggressive non-Hodgkin’s lymphoma, originating from naı ¨ve B-cells. The blastoid MCL tumors often show complex cytogenetic aberrations. In this review, we summarized the data available on immunoglobulin heavy-cha
Externí odkaz:
https://doaj.org/article/2d57760856174764bc234a8fb305d392
Autor:
Xu-Chen Cao, Wei-Ran Zhang, Wen-Feng Cao, Bo-Wen Liu, Fei Zhang, Hong-Meng Zhao, Ran Meng, Lin Zhang, Rui-Fang Niu, Xi-Shan Hao, Bin Zhang
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e56735 (2013)
PURPOSE: The aquaporin (AQP) family consists of a number of small integral membrane proteins that transport water and glycerol. AQPs are critical for trans-epithelial fluid transport. Recent reports demonstrated that AQPs, particularly AQP1 and AQP5,
Externí odkaz:
https://doaj.org/article/a16d778121044b459df378da8d43d881
Autor:
Li Jun Tian, Juan Wang, Chao Jiang, Guo Guang Ying, Mao Bin Meng, Huan Huan Wang, Xi Shan Hao, Zhiqiang Wu, Zhi Yong Yuan, Chun Lei Liu, Xian Liang Zeng, Jing Jing Cheng, Ming Han Qiu, Dong Qian, Nicholas G. Zaorsky
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 101:49-62
Purpose To investigate how necroptosis (ie, programmed necrosis) is involved in killing of non-small cell lung cancer (NSCLC) after ablative hypofractionated radiation therapy (HFRT). Methods and Materials Deoxyribonucleic acid damage, DNA repair, an
Autor:
Jing Yu Deng, Han Liang, Xing Ming Xie, Xi Shan Hao, Jing Li Cui, Guo Guang Ying, Wei Peng Wu, Qiu Ping Dong, Ya Chao Hou
Publikováno v:
Cancer Biomarkers. 15:259-265
BACKGROUND E3 ubiquitin ligase Ring finger protein 180 (RNF180) has been identified as a novel tumor suppressor in gastric cancer and the methylated CpG site count of RNF180 DNA promoter can predict the prognosis for gastric cancer patients. OBJECTIV
Autor:
Hua-Qing, Wang, Yangang, Ren, Zheng-Zi, Qian, Kai, Fu, Hui-Lai, Zhang, Wei, Li, Yun, Hou, Shi-Yong, Zhou, Xi-Shan, Hao, Cong-Hua, Xie
Publikováno v:
Thoracic cancer. 3(1)
To evaluate the efficacy and safety of nimotuzumab combined with gemcitabine and cisplatin as second-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) and to investigate the association of the status of KRAS gene mutation and epiderma
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 15:6411-6414
Background: A dense breast not only reduces the sensitivity of mammography but also is a moderate independent risk factor for breast cancer. The percentage of Western women with fat breast tissue is higher aged 40 years or older. To a certain extent,
Autor:
Shi Yong Zhou, Xianhuo Wang, Zheng Zi Qian, Huaqing Wang, Zheng Song, Ping Wang, Xi Shan Hao, Li Hua Qiu, Hui Lai Zhang, Jing Zhao
Publikováno v:
Expert Opinion on Drug Metabolism & Toxicology. 9:117-125
The purpose of this study was to investigate the maximum tolerated dose (MTD), dose-limiting toxicity (DLT), and pharmacokinetics of ursolic acid liposomes (UAL), as a new drug, in healthy adult volunteers and patients with advanced solid tumors.All
Autor:
Zheng Zi Qian, Yangang Ren, Shi Yong Zhou, Wei Li, Yun Hou, Hui Lai Zhang, Xi Shan Hao, Kai Fu, Cong Hua Xie, Huaqing Wang
Publikováno v:
Thoracic Cancer. 3:72-78
Objective: To evaluate the efficacy and safety of nimotuzumab combined with gemcitabine and cisplatin as second-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) and to investigate the association of the status of KRAS gene mutation a
Publikováno v:
Journal of Gastrointestinal Surgery. 15:1026-1034
The incidence of pancreatic cancer has increased in China in the last decade, though efforts have been made in early detection and multimodality treatment. The aim of this study is to describe the decade-based development in early diagnosis and treat
Publikováno v:
The Endocrinologist. 18:77-80